| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |